SHEILA THOMAS: Open Payments
NPI 1235148305 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 31 payments from 13 companies in 2025. Trend: 2023 $610 · 2024 $659 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 5 | $125 |
| Gilead Sciences, Inc. | 5 | $119 |
| Otsuka America Pharmaceutical, Inc. | 4 | $91 |
| ABBVIE INC. | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $81 |
| Antares Pharma, Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: DOVATO, REXULTI, CAPLYTA, VRAYLAR, XYOSTED, SPRAVATO, Veozah, Auvelity.
Industry payments across KS — which companies pay providers there.
